These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 11159746)
1. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Hulla JE; French JE; Dunnick JK Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747 [TBL] [Abstract][Full Text] [Related]
3. Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein. Hulla JE; French JE; Dunnick JK Toxicol Sci; 2001 Apr; 60(2):264-70. PubMed ID: 11248138 [TBL] [Abstract][Full Text] [Related]
4. Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein. Hulla JE Toxicol Sci; 2001 Dec; 64(2):281-2. PubMed ID: 11719711 [No Abstract] [Full Text] [Related]
5. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination. Boley SE; Anderson EE; French JE; Donehower LA; Walker DB; Recio L Cancer Res; 2000 Jun; 60(11):2831-5. PubMed ID: 10850423 [TBL] [Abstract][Full Text] [Related]
6. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice. Dunnick JK; Hardisty JF; Herbert RA; Seely JC; Furedi-Machacek EM; Foley JF; Lacks GD; Stasiewicz S; French JE Toxicol Pathol; 1997; 25(6):533-40. PubMed ID: 9437796 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317 [TBL] [Abstract][Full Text] [Related]
8. Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas. Shimada Y; Nishimura M; Kakinuma S; Okumoto M; Shiroishi T; Clifton KH; Wakana S Radiat Res; 2000 Sep; 154(3):293-300. PubMed ID: 10956435 [TBL] [Abstract][Full Text] [Related]
9. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens. French J; Storer RD; Donehower LA Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559 [TBL] [Abstract][Full Text] [Related]
10. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204 [TBL] [Abstract][Full Text] [Related]
11. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131 [TBL] [Abstract][Full Text] [Related]
12. Motif-primed polymerase chain reaction-based allelotype of sarcomas induced by 3-methylcholanthrene in interspecific hybrid mice. Dudley ME; Sundberg JP; Roopenian DC Oncogene; 1995 Aug; 11(3):517-24. PubMed ID: 7630636 [TBL] [Abstract][Full Text] [Related]
13. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Hegi ME; Söderkvist P; Foley JF; Schoonhoven R; Swenberg JA; Kari F; Maronpot R; Anderson MW; Wiseman RW Carcinogenesis; 1993 May; 14(5):803-10. PubMed ID: 8504472 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice. Delker DA; Yano BL; Gollapudi BB Toxicol Sci; 2000 Jun; 55(2):361-9. PubMed ID: 10828268 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of recombinant chromosomes and low fidelity of transmission of chromosome X DNA markers in gamma-ray-induced lymphomas lacking p53. Koide N; Matsumoto Y; Kosugi S; Chou D; Sakai K; Hatakeyama K; Niwa O; Kominami R Mol Carcinog; 1999 Jan; 24(1):57-63. PubMed ID: 10029411 [TBL] [Abstract][Full Text] [Related]
16. Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors. Shetzer Y; Napchan Y; Kaufman T; Molchadsky A; Tal P; Goldfinger N; Rotter V Int J Cancer; 2017 Mar; 140(6):1364-1369. PubMed ID: 28008605 [TBL] [Abstract][Full Text] [Related]
17. Phenolphthalein and bisacodyl: assessment of genotoxic and carcinogenic responses in heterozygous p53 (+/-) mice and syrian hamster embryo (SHE) assay. Stoll RE; Blanchard KT; Stoltz JH; Majeska JB; Furst S; Lilly PD; Mennear JH Toxicol Sci; 2006 Apr; 90(2):440-50. PubMed ID: 16373391 [TBL] [Abstract][Full Text] [Related]
18. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas. Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus. French JE IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301 [TBL] [Abstract][Full Text] [Related]
20. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Hulla JE Carcinogenesis; 2001 Nov; 22(11):1891. PubMed ID: 11698354 [No Abstract] [Full Text] [Related] [Next] [New Search]